Weijun Xu - Concepedia

Author

Weijun Xu

The University of Queensland ORCID

Also Known As

W Xu, W. Xu, W.-M. Xu, WEIJUN XU, Wang-Bing Xu, Wanjing Xu, Wei-Jun Xu, Weijun Xu, Wenwei XU

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

The University of Queensland Singapore Polytechnic Chinese Academy of Sciences Shanghai Institute of Materia Medica Translational Research Institute

About

Weijun Xu is an author at The University of Queensland specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	601
2	Biochemistry	8	8	514
3	Natural Sciences	4	4	187
4	Biomolecular Engineering	1	1	79
5	Cell Biology	1	1	22

Weijun Xu

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features Lili Chen, Jian Li, Cheng Luo, Bioorganic & Medicinal Chemistry Molecular PharmacologyPharmaceutical ScienceBiochemistrySars-cov 3ClproMedicine	2006	267
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth Ming Jang Chua, Megan Arnold, Weijun Xu, International Journal for Parasitology Drugs and Drug Resistance	2016	102
Class IIa Histone Deacetylases Drive Toll-like Receptor-Inducible Glycolysis and Macrophage Inflammatory Responses via Pyruvate Kinase M2 Kaustav Das Gupta, Melanie R. Shakespear, James E. B. Curson, Cell Reports	2020	89
Potent Cationic Inhibitors of West Nile Virus NS2B/NS3 Protease With Serum Stability, Cell Permeability and Antiviral Activity Martin J. Stoermer, Keith J. Chappell, Susann Liebscher, Journal of Medicinal Chemistry	2008	83
Discovery of Novel Small Molecule Inhibitors of Dengue Viral NS2B-NS3 Protease Using Virtual Screening and Scaffold Hopping Jing Deng, Ning Li, Hongchuan Liu, Journal of Medicinal Chemistry Synthetic VirologyMolecular BiologyPeptide ScienceAntiviral DrugViral Structural Protein	2012	79
Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets Weijun Xu, Andrew J. Lucke, David P. Fairlie Journal of Molecular Graphics and Modelling Molecular DockingProtein TargetsDrug TargetBiochemistryNatural Sciences	2015	75
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells Yuhong Jiang, Mei‐Kwan Yau, Junxian Lim, Journal of Pharmacology and Experimental Therapeutics	2017	64
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists Vernon Seow, Junxian Lim, Adam J. Cotterell, Scientific Reports	2016	45
PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR Yuhong Jiang, Junxian Lim, Kai‐Chen Wu, British Journal of Pharmacology	2020	34
A Novel NKX2.6 Mutation Associated with Congenital Ventricular Septal Defect Juan Wang, Jianhui Mao, Keke Ding, Pediatric Cardiology ImmunologyPathologyCongenital Heart DefectCongenital Heart AnomalyMedicine	2014	28

Page 1